NCT01392560
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- 1245.46.10001 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
NCT01392560
NCT01269606
NCT01689129
NCT00252720
Not specified
NCT01098994
NCT01109797
NCT02073058
NCT01825382
NCT00938405
NCT00252733